NEWS
Our Latest News
ARCHIMED closes MED IV fund at €1.5 billion ($1.75 billion) hard cap, three times oversubscribed, in less than six months of fundraising.
ARCHIMED closes MED IV fund at €1.5 billion ($1.75 billion) hard cap, three times oversubscribed, in less than six months of fundraising
September
9,
2026
ARCHIMED Life Science Tools & Services acquires IRAB, a leading independent radiopharmaceuticals platform
June
9,
2026
368